Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00694837
What this trial is testing

Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma

Who this might be right for
Glioblastoma
Maastricht Radiation Oncology 6
Early research (Phase 1)Study completedNCT00720564
What this trial is testing

Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT01920191
What this trial is testing

Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma

Who this might be right for
CNS Tumor, Adult
University Hospital, Geneva 19
Testing effectiveness (Phase 2)Study completedNCT00047294
What this trial is testing

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dana-Farber Cancer Institute
Large-scale testing (Phase 3)Looking for participantsNCT06419946
What this trial is testing

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Vastra Gotaland Region 200
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Ended earlyNCT06359379
What this trial is testing

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

Who this might be right for
Glioblastoma, IDH-wildtype
Shuttle Pharmaceuticals, Inc. 30
Early research (Phase 1)Study completedNCT03514069
What this trial is testing

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Who this might be right for
GliomaGlioblastoma
Case Comprehensive Cancer Center 60
Early research (Phase 1)Study completedNCT00390403
What this trial is testing

Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Not applicableUnknownNCT04856852
What this trial is testing

Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
The Affiliated Hospital of Qingdao University 84
Testing effectiveness (Phase 2)Study completedNCT00662506
What this trial is testing

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 46
Very early researchStudy completedNCT01957956
What this trial is testing

Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Giant Cell GlioblastomaGlioblastomaGliosarcoma
Mayo Clinic 21
Testing effectiveness (Phase 2)Study completedNCT00902577
What this trial is testing

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00100802
What this trial is testing

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

Who this might be right for
Anaplastic AstrocytomaCentral Nervous System NeoplasmGlioblastoma+2 more
Children's Oncology Group 118
Testing effectiveness (Phase 2)Study completedNCT00684567
What this trial is testing

Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Study completedNCT01062425
What this trial is testing

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Adult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 261
Testing effectiveness (Phase 2)Active Not RecruitingNCT02649582
What this trial is testing

Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients

Who this might be right for
Glioblastoma Multiforme of Brain
University Hospital, Antwerp 20
Testing effectiveness (Phase 2)Ended earlyNCT03927222
What this trial is testing

Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

Who this might be right for
Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 6
Very early researchLooking for participantsNCT05423210
What this trial is testing

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Stony Brook University 12
Testing effectiveness (Phase 2)Ended earlyNCT03897491
What this trial is testing

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Who this might be right for
Glioblastoma
photonamic GmbH & Co. KG 17
Next Page